Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

KCNQ3 binds 1A and syntaxin. 1 / 1

| 1

➶

reach

"However, because the in vitro binding of KCNQ3 were not significantly different from those of KCNQ2, and KCNQ3 still bound syntaxin 1A in vivo (albeit weakly as compared to KCNQ2), it may well be that the differences in syntaxin 1A functional potencies between KCNQ2 and KCNQ3 may not be due to the differential binding affinities, but rather to differential coupling efficiencies between syntaxin 1A binding domain and the gating and/or conductance machinery."

19675672

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...